SCOPUS 정보 검색 플랫폼

FASEB Journal

Volumn 15, Issue 10, 2001, Pages 1671-1676

Foundations for blockbuster drugs in federally sponsored research

(1) Thompson, Richard B a

a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE (United States)

Author keywords

Cholesterol; HMG CoA reductase; Mevastatin; Research funding; Statins

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HYPOCHOLESTEROLEMIC AGENT; PRAVASTATIN; SIMVASTATIN;

COST; MEDICAL RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS;

ANTICHOLESTEREMIC AGENTS; CARDIOVASCULAR DISEASES; DRUG COSTS; DRUG DESIGN; FINANCING, GOVERNMENT; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; NATIONAL INSTITUTES OF HEALTH (U.S.); RESEARCH SUPPORT; UNITED STATES;

EID: 0034902213 PISSN: 08926638 EISSN: None Source Type: Journal
DOI: 10.1096/fj.01-0024lsf Document Type: Review

Times cited : (120)

References (18)

1
- 84942223275
- Uber des gehalt normaler und atheromatöser aorten an cholesterin und cholesterinestern
- (1910) Hoppe-Seyler's Z. Physiol. Chem. , vol.67 , pp. 174-176
- Windaus, A.¹

2
- 0001910351
- Experimental cholesterolsteatosis and its significance for the etiology of certain pathological processes
- (1913) Zentralblatt der Allegemeine Pathologie und Anatomie , vol.24 , pp. 1-9
- Anitschkow, N.¹ Chalatow, S.²

3
- 72949132104
- Factors of risk in the development of coronary artery disease - Six year followup experience: The Framingham study
- (1961) Ann. Int. Med. , vol.55 , pp. 33-50
- Kannel, W.B.¹ Dawber, T.R.² Kagan, A.³ Revotskie, N.⁴ Stoke, J.⁵

4
- 0027987849
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin survival study (4S)
- (1994) Lancet , vol.344 , pp. 1383-1389

5
- 74949092744
- National Heart, Lung, and Blood Institute, Bethesda, Maryland
- (1999) Fact Book

6
- 0002380192
- The biological synthesis of cholesterol
- (1965) Science , vol.150 , pp. 19-28
- Bloch, K.¹

7
- 0000932365
- The reduction of beta-hydroxy-beta-methylglutaryl coenzyme A to mevalonic acid
- (1960) J. Biol. Chem. , vol.235 , pp. 2572-2578
- Durr, I.F.¹ Rudney, H.²

8
- 0015039220
- Hypocholesterolemic agents. I. 3-methyl-4-phenylbutenoic acids
- (1971) J. Pharm. Sci. , vol.60 , pp. 614-616
- Boots, S.G.¹ Boots, M.R.² Guyer, K.E.³

9
- 0015632094
- Hypocholesterolemic agents. II. Inhibition of 2-hydroxy-2-methylglutaryl coenzyme A reductase by aryl alkyl hydrogen succinates and glutarates
- (1973) J. Pharm. Sci. , vol.62 , pp. 952-957
- Boots, M.R.¹ Boots, S.G.² Noble, C.M.³ Guyer, K.E.⁴

10
- 0017043554
- Competitive inhibition of HMG CoA reductase by ML-236A and ML-236B: Fungal metabolites having hypocholesterolemic activity
- (1976) FEBS Lett. , vol.72 , pp. 323-326
- Endo, A.¹ Kuroda, M.² Tanzawa, K.³

11
- 0017055252
- ML-236A, ML236B, and ML-236C. New inhibitors of cholesterogenesis produced by Penicillium citrinum
- (1976) J. Antibiotics , vol.29 , pp. 1346-1348
- Endo, A.¹ Kuroda, M.² Tsujita, Y.³

12
- 0016913421
- Crystal and molecular structure of compactin, a new antifungal metabolite from Penicillium brevicompactum
- (1976) J. Chem. Soc. Perkins Trans. , vol.1 , pp. 1165-1170
- Brown, A.G.¹ Smale, T.C.² King, T.J.³ Hasenkamp, R.⁴ Thompson, R.H.⁵

13
- 0018939225
- Mevinolin: A highly potent competitive inhibitor of HMG CoA reductase and a cholesterol-lowering agent
- (1980) Proc. Natl. Acad. Sci. USA , vol.77 , pp. 3957-3961
- Alberts, A.W.¹ Chen, J.² Kuron, G.³ Hunt, V.⁴ Huff, J.⁵ Hoffman, C.⁶ Rothrock, J.⁷ Lopez, M.⁸ Joshua, H.⁹ Harris, E.¹⁰

14
- 0004411112
- Merck and Co., Whitehouse Station, New Jersey
- (1998) Annual Report to Shareholders

15
- 0034161543
- Crystal structure of the catalytic portion 19 human HMG-CoA reductase: Insights into regulation of activity and catalysis
- (2000) EMBO J. , vol.19 , pp. 819-830
- Istvan, E.S.¹ Palnitkar, M.² Buchanan, S.K.³ Deisenhofer, J.⁴

16
- 0028243847
- Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries
- (1994) J. Med. Chem. , vol.37 , pp. 1233-1251
- Gallop, M.A.¹ Barrett, R.W.² Dower, W.J.³ Fodor, S.P.A.⁴ Gordon, E.M.⁵

17
- 0028318863
- Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions
- (1994) J. Med. Chem. , vol.37 , pp. 1385-1401
- Gordon, E.M.¹ Barrett, R.W.² Dower, W.J.³ Fodor, S.P.A.⁴ Gallop, M.A.⁵

18
- 0001849896
- Companies look to outsource chemistry
- (2000) Drug Discovery , vol.5 , pp. 44-46
- Tapolczay, D.¹ Cush, S.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.